Close Menu
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Manama BuzzManama Buzz
    • Home
    • Contact Us
    Manama BuzzManama Buzz
    Home » Maypharm’s Hyalmass filler with Hybrid Technology obtained CE to hit Europe and America’s market
    PR Newswire

    Maypharm’s Hyalmass filler with Hybrid Technology obtained CE to hit Europe and America’s market

    April 18, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SEOUL, South Korea and NEW YORK, April 18, 2023 /PRNewswire/ — Being already popular on South Asia market, particularly in Vietnam, Philippines, Thailand, China, for Hybrid Technology and highly dense HA for long-lasting effect, Hyalmass filler obtains CE to properly enter Europe, America etc markets.

    Along with Metoo fill, Sedy fill, Metox, Mennus, Hairna and Eyebella, Hyalmass has passed a ton of exacting clinical preliminaries to guarantee device’s performance. It was developed by adding a local anaesthetic lidocaine to lessen pain during the procedure. It also contains a soft tissue material hyaluronic acid and aimed at temporary improvement of wrinkles. Hyalmass is made of a homogenized hyaluronic acid, which is Maypharm’s own product that creates a high bio-compatibility rate.

    Hyalmass is a cosmetic treatment that aims to restore volume and smooth out wrinkles in the face. This procedure is performed using hyaluronic acid, a naturally occurring substance in the body that provides hydration and fullness to the skin.

    Unique push rod of Hyalmass was designed to enable the user to insert it for the procedure with less effort. The handle design is specially developed to fit various sizes of hands and prevent from slipping.

    Maypharm’s Hyalmass filler

    Main benefit of using Hyalmass filler is immediate and noticeable results. After the treatment, patients can expect to see an improvement in the appearance of wrinkles, fine lines, and sagging skin, as well as an increase in overall facial volume. The results can last for up to 12 months and the treatment is safe and effective for most people.

    In addition to its cosmetic benefits, the Hyalmass filler can also have a positive impact on a person’s confidence and self-esteem. By restoring volume and smoothing out wrinkles, patients can feel more youthful and refreshed, which can lead to an improvement in their overall well-being.

    In conclusion, Hyalmass filler is a popular cosmetic treatment that offers a simple and effective solution for restoring volume and smoothing out wrinkles in the face. Whether you look forward to improving your appearance or boosting your confidence, this treatment is the best option to consider.

    Maypharm is looking forward to becoming well-known manufacturer of dermal fillers for their safety and efficiency, and being on highest demand on every market, Asia, Middle East and Africa or South and North America.

    Maypharm’s Hyalmass filler

    Visit the website for detailed information: http://www.maypharm.net

    Photo – https://mma.prnewswire.com/media/2056663/Maypharm_s_Hyalmass_filler.jpg
    Photo – https://mma.prnewswire.com/media/2056664/Maypharm_s_Hyalmass_filler.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/maypharms-hyalmass-filler-with-hybrid-technology-obtained-ce-to-hit-europe-and-americas-market-301800102.html

    Related Posts

    ARTPRICE NEWS: A WORLD-BOOK BECOMES A MIRROR FOR ARTIFICIAL INTELLIGENCE

    September 18, 2026

    Cricket Legend Brett Lee Named ‘Chief Celebration Officer’ of The UAE Lottery

    September 18, 2026

    Jiahui Health Highlights China’s Growing Role in Global Medical Tourism at WTO Public Forum 2026

    September 18, 2026

    Huawei Unveils Innovative Immersive Telepresence Solution That Offers Immersive Experiences and Intelligent Services

    September 18, 2026

    Carestream Healthcare International Launches STARVIEW Digital Radiography System

    September 18, 2026

    PharmaResearch Launches REJURAN in Saudi Arabia, Expanding Presence Across the Middle East

    September 18, 2026
    Latest News

    WHO reports Ebola progress as DR Congo outbreak continues

    September 17, 2026

    Gold prices decline on Federal Reserve rate decision in trading

    September 17, 2026

    Nepal flood missing count rises to 6,150 after verification

    September 17, 2026

    Apple adds first foldable iPhone to lineup with iPhone Duo

    September 16, 2026
    © 2026 Manama Buzz | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.